Lebeck J, Cheema MU, Skowronski MT, Nielsen S, Praetorius J. Hepatic AQP9 expression in male rats is reduced in response to PPAR␣ agonist treatment. Am J Physiol Gastrointest Liver Physiol 308: G198 -G205, 2015. First published December 4, 2014 doi:10.1152/ajpgi.00407.2013.-The peroxisome proliferator receptor ␣ (PPAR␣) is a key regulator of the hepatic response to fasting with effects on both lipid and carbohydrate metabolism. A role in hepatic glycerol metabolism has also been found; however, the results are somewhat contradictive. Aquaporin 9 (AQP9) is a pore-forming transmembrane protein that facilitates hepatic uptake of glycerol. Its expression is inversely regulated by insulin in male rodents, with increased expression during fasting. Previous results indicate that PPAR␣ plays a crucial role in the induction of AQP9 mRNA during fasting. In the present study, we use PPAR␣ agonists to explore the effect of PPAR␣ activation on hepatic AQP9 expression and on the abundance of enzymes involved in glycerol metabolism using both in vivo and in vitro systems. In male rats with free access to food, treatment with the PPAR␣ agonist WY 14643 (3 mg·kg Ϫ1 ·day Ϫ1 ) caused a 50% reduction in hepatic AQP9 abundance with the effect being restricted to AQP9 expressed in periportal hepatocytes. The pharmacological activation of PPAR␣ had no effect on the abundance of GlyK, whereas it caused an increased expression of hepatic GPD1, GPAT1, and L-FABP protein. In WIF-B9 and HepG2 hepatocytes, both WY 14643 and another PPAR␣ agonist GW 7647 reduced the abundance of AQP9 protein. In conclusion, pharmacological PPAR␣ activation results in a marked reduction in the abundance of AQP9 in periportal hepatocytes. Together with the effect on the enzymatic apparatus for glycerol metabolism, our results suggest that PPAR␣ activation in the fed state directs glycerol into glycerolipid synthesis rather than into de novo synthesis of glucose. aquaporin-9; immunohistochemistry; WY 14643; hepatocytes; glycerol metabolism PEROXISOME PROLIFERATOR RECEPTOR ␣ (PPAR␣) is a ligandactivated transcription factor that belongs to the superfamily of nuclear hormone receptors (39). After binding of ligands such as free fatty acids and fibrates, PPAR␣ and its coactivators influence the transcription of target genes either by binding to response elements in the corresponding promoter region (PPREs) or by interfering with other transcription factors (39). Fibrates are used in the treatment of hypertriglyceridemia and PPAR␣ regulates the expression of several proteins involved in lipid metabolism that promotes the removal of triglycerides (TG) from the circulation and enhances -oxidation and ketogenesis in the liver (11). The induction of these pathways is particularly vital during starvation and PPAR␣ knockout (KO) mice respond to fasting with hypoketonemia, hypothermia, and hypoglycemia (12). Several mechanisms have been proposed to explain the fasting-induced hypoglycemia, including decreased hepatic glucose production (12, 21) as well as increased extr...